跳至主要内容
临床试验/EUCTR2014-001550-42-AT
EUCTR2014-001550-42-AT进行中(未招募)1 期

Patient stratification and treatment response prediction in neuropharmacotherapy using PET/MR – Predicting drug efficacy using hybrid PET/MR imaging with pharmacological challenge and multireceptor modeling - Pharmaco-PET/MR to Predict Antidepressant Drug Efficacy

Medizinische Universität Wien0 个研究点目标入组 195 人开始时间: 2014年5月7日最近更新:
适应症
相关药物

试验速览

阶段
1 期
状态
进行中(未招募)
入组人数
195

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional clinical trial of medicinal product

入排标准

性别
All

入选标准

  • General health based on medical history, physical examination and structured clinical interview for DSM-IV (SCID)
  • Age 18 to 55 years
  • HAM-D >17 (MDD patients)
  • Are the trial subjects under 18? no
  • Number of subjects for this age range:
  • F.1.2 Adults (18-64 years) yes
  • F.1.2.1 Number of subjects for this age range 195
  • F.1.3 Elderly (>=65 years) no
  • F.1.3.1 Number of subjects for this age range

排除标准

  • Any medical, psychiatric or neurological illness (other than MDD)
  • Psychopharmacological treatment within 3 months prior to inclusion (excepting occasional intake of antihistamines and benzodiazepines, given a wash-out of at least one day prior to PET/MR measurements)
  • Current or former substance abuse (excepting nicotine)
  • Any implant or stainless steel graft or any other contraindications for MRI
  • Participation in studies involving radiation exposure in the past 10 years.
  • Body mass index <17 or >30

研究者

相似试验